PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UTMD vs. DHR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


UTMDDHR
YTD Return-20.27%16.22%
1Y Return-20.07%26.99%
3Y Return (Ann)-7.97%0.51%
5Y Return (Ann)-5.58%17.50%
10Y Return (Ann)4.37%24.29%
Sharpe Ratio-0.851.21
Sortino Ratio-1.201.93
Omega Ratio0.871.22
Calmar Ratio-0.450.76
Martin Ratio-1.176.68
Ulcer Index17.14%4.18%
Daily Std Dev23.73%23.09%
Max Drawdown-76.72%-65.35%
Current Drawdown-43.70%-7.88%

Fundamentals


UTMDDHR
Market Cap$230.57M$193.57B
EPS$4.33$5.45
PE Ratio15.3049.18
PEG Ratio0.002.70
Total Revenue (TTM)$34.07M$14.23B
Gross Profit (TTM)$18.74M$8.54B
EBITDA (TTM)$14.55M$4.88B

Correlation

-0.50.00.51.00.1

The correlation between UTMD and DHR is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

UTMD vs. DHR - Performance Comparison

In the year-to-date period, UTMD achieves a -20.27% return, which is significantly lower than DHR's 16.22% return. Over the past 10 years, UTMD has underperformed DHR with an annualized return of 4.37%, while DHR has yielded a comparatively higher 24.29% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%15.00%MayJuneJulyAugustSeptemberOctober
-1.12%
12.19%
UTMD
DHR

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UTMD vs. DHR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UTMD
Sharpe ratio
The chart of Sharpe ratio for UTMD, currently valued at -0.85, compared to the broader market-4.00-2.000.002.004.00-0.85
Sortino ratio
The chart of Sortino ratio for UTMD, currently valued at -1.20, compared to the broader market-4.00-2.000.002.004.00-1.20
Omega ratio
The chart of Omega ratio for UTMD, currently valued at 0.87, compared to the broader market0.501.001.502.000.87
Calmar ratio
The chart of Calmar ratio for UTMD, currently valued at -0.45, compared to the broader market0.002.004.006.00-0.45
Martin ratio
The chart of Martin ratio for UTMD, currently valued at -1.17, compared to the broader market-10.000.0010.0020.0030.00-1.17
DHR
Sharpe ratio
The chart of Sharpe ratio for DHR, currently valued at 1.21, compared to the broader market-4.00-2.000.002.004.001.21
Sortino ratio
The chart of Sortino ratio for DHR, currently valued at 1.93, compared to the broader market-4.00-2.000.002.004.001.93
Omega ratio
The chart of Omega ratio for DHR, currently valued at 1.22, compared to the broader market0.501.001.502.001.22
Calmar ratio
The chart of Calmar ratio for DHR, currently valued at 0.76, compared to the broader market0.002.004.006.000.76
Martin ratio
The chart of Martin ratio for DHR, currently valued at 6.68, compared to the broader market-10.000.0010.0020.0030.006.68

UTMD vs. DHR - Sharpe Ratio Comparison

The current UTMD Sharpe Ratio is -0.85, which is lower than the DHR Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of UTMD and DHR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50MayJuneJulyAugustSeptemberOctober
-0.85
1.21
UTMD
DHR

Dividends

UTMD vs. DHR - Dividend Comparison

UTMD's dividend yield for the trailing twelve months is around 1.81%, more than DHR's 0.39% yield.


TTM20232022202120202019201820172016201520142013
UTMD
Utah Medical Products, Inc.
1.81%1.41%1.16%2.84%1.31%1.01%1.28%1.28%1.41%1.72%1.64%1.69%
DHR
Danaher Corporation
0.39%0.43%0.38%0.26%0.32%0.44%0.62%0.60%36.46%0.80%0.47%0.13%

Drawdowns

UTMD vs. DHR - Drawdown Comparison

The maximum UTMD drawdown since its inception was -76.72%, which is greater than DHR's maximum drawdown of -65.35%. Use the drawdown chart below to compare losses from any high point for UTMD and DHR. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%MayJuneJulyAugustSeptemberOctober
-43.70%
-7.88%
UTMD
DHR

Volatility

UTMD vs. DHR - Volatility Comparison

The current volatility for Utah Medical Products, Inc. (UTMD) is 3.34%, while Danaher Corporation (DHR) has a volatility of 5.82%. This indicates that UTMD experiences smaller price fluctuations and is considered to be less risky than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%MayJuneJulyAugustSeptemberOctober
3.34%
5.82%
UTMD
DHR

Financials

UTMD vs. DHR - Financials Comparison

This section allows you to compare key financial metrics between Utah Medical Products, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items